{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:49:27Z","timestamp":1761518967899,"version":"build-2065373602"},"reference-count":46,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2010,10,1]],"date-time":"2010-10-01T00:00:00Z","timestamp":1285891200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone & IGF Research"],"published-print":{"date-parts":[[2010,10]]},"DOI":"10.1016\/j.ghir.2010.05.003","type":"journal-article","created":{"date-parts":[[2010,7,5]],"date-time":"2010-07-05T04:21:29Z","timestamp":1278303689000},"page":"333-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Growth hormone status predicts left ventricular mass in patients after cure of acromegaly"],"prefix":"10.1016","volume":"20","author":[{"given":"Tamara L.","family":"Wexler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronen","family":"Durst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael H.","family":"Picard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lindsay","family":"Gunnell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zehra","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pouneh","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karen K.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Klibanski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2010.05.003_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/j.1365-2265.1994.tb03789.x","article-title":"Determinants of clinical outcome and survival in acromegaly","volume":"41","author":"Rajasoorya","year":"1994","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"Suppl 5","key":"10.1016\/j.ghir.2010.05.003_bib2","first-page":"166","article-title":"Excess mortality in acromegaly","volume":"68","author":"Holdaway","year":"2007","journal-title":"Horm. Res."},{"key":"10.1016\/j.ghir.2010.05.003_bib3","first-page":"3419","article-title":"Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly","volume":"83","author":"Swearingen","year":"1998","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1210\/jc.2003-031199","article-title":"Factors influencing mortality in acromegaly","volume":"89","author":"Holdaway","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib5","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/er.2003-0009","article-title":"Cardiovascular function in acromegaly","volume":"24","author":"Clayton","year":"2003","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.ghir.2010.05.003_bib6","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/0002-9343(79)90477-7","article-title":"Acromegaly and the heart, an echocardiographic study","volume":"66","author":"Smallridge","year":"1979","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ghir.2010.05.003_bib7","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1378\/chest.72.4.495","article-title":"Dysrhythmias and sudden death in acromegalic heart disease. A clinicopathologic study","volume":"72","author":"Rossi","year":"1977","journal-title":"Chest"},{"key":"10.1016\/j.ghir.2010.05.003_bib8","first-page":"1047","article-title":"Cardiac involvement in acromegaly: specific myocardiopathy or consequence of systemic hypertension?","volume":"82","author":"Lopez-Velasco","year":"1997","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib9","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1159\/000095530","article-title":"Acromegaly and the cardiovascular system","volume":"83","author":"Lombardi","year":"2006","journal-title":"Neuroendocrinology"},{"key":"10.1016\/j.ghir.2010.05.003_bib10","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/BF03344070","article-title":"Improvement of left ventricular hypertrophy and arrhythmias after lanreotide-induced GH and IGF-I decrease in acromegaly. A prospective multi-center study","volume":"25","author":"Lombardi","year":"2002","journal-title":"J. Endocrinol. Invest."},{"key":"10.1016\/j.ghir.2010.05.003_bib11","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.2001.01218.x","article-title":"Growth hormone and the heart","volume":"54","author":"Colao","year":"2001","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2010.05.003_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1210\/jcem.85.1.6313","article-title":"Cardiovascular effects of short-term growth hormone hypersecretion","volume":"85","author":"Fazio","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1161\/01.CIR.99.11.1426","article-title":"Cell death in acromegalic cardiomyopathy","volume":"99","author":"Frustaci Test","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2010.05.003_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1172\/JCI116579","article-title":"Endothelin-1 is an autocrine\/paracrine factor in the mechanism of angiotensin II-induced hypertrophy in cultured rat cardiomyocytes","volume":"92","author":"Ito","year":"1993","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2010.05.003_bib15","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1046\/j.1365-2265.1998.00493.x","article-title":"Echocardiographic evidence for a direct effect of GH\/IGF-I hypersecretion on cardiac mass and function in young acromegalics","volume":"49","author":"Minniti","year":"1998","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2010.05.003_bib16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jc.2006-1587","article-title":"Treatment with growth hormone receptor antagonist in acromegaly: effect on cardiac structure and performance","volume":"92","author":"Pivonello","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib17","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1210\/jc.2006-2547","article-title":"Impact of somatostatin analogs on the heart in acromegaly: a metaanalysis","volume":"92","author":"Maison","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib18","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1210\/jc.2008-0299","article-title":"Impact of treating acromegaly first with surgery or somatostatin analogs on cardiomyopathy","volume":"93","author":"Colao","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11102-007-0062-6","article-title":"The long-term cardiovascular outcome of different GH-lowering treatments in acromegaly","volume":"11","author":"De Marinis","year":"2008","journal-title":"Pituitary"},{"key":"10.1016\/j.ghir.2010.05.003_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/0140-6736(90)91812-O","article-title":"Premature mortality due to cardiovascular disease in hypopituitarism","volume":"336","author":"Rosen","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2010.05.003_bib21","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1210\/jc.2007-2371","article-title":"Growth hormone (GH) decreases visceral fat and improves cardiovascular risk (CV) markers in women with hypopituitarism: a randomized, placebo-controlled study","volume":"93","author":"Beauregard","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib22","doi-asserted-by":"crossref","first-page":"4664","DOI":"10.1210\/jc.2007-1636","article-title":"Congenital growth hormone (GH) deficiency and atherosclerosis: effects of GH replacement in GH-naive adults","volume":"92","author":"Oliveira","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib23","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1210\/jc.2005-2566","article-title":"The natural history of partial growth hormone deficiency in adults: a prospective study on the cardiovascular risk and atherosclerosis","volume":"91","author":"Colao","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib24","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1365-2265.1992.tb02347.x","article-title":"The growth hormone deficiency syndrome in adults","volume":"37","author":"Cuneo","year":"1992","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2010.05.003_bib25","first-page":"833","article-title":"Body composition in adult growth hormone-deficient men, assessed by anthropometry and bioimpedance analysis","volume":"75","author":"De Boer","year":"1992","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib26","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/ajcn\/55.5.918","article-title":"Body composition in growth hormone-deficient adults","volume":"55","author":"Binnerts","year":"1992","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ghir.2010.05.003_bib27","first-page":"153","article-title":"The effect of low dose recombinant human growth hormone replacement on regional fat distribution, insulin sensitivity, and cardiovascular risk factors in hypopituitary adults","volume":"8","author":"Weaver","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2265.2006.02518.x","article-title":"Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency","volume":"64","author":"Gomez","year":"2006","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2010.05.003_bib29","doi-asserted-by":"crossref","first-page":"5146","DOI":"10.1210\/jc.2005-0597","volume":"90","author":"Colao","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib30","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.ghir.2010.05.003_bib31","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1210\/jcem.87.5.8474","article-title":"Familial isolated growth hormone deficiency is associated with increased systolic blood pressure, central obesity, and dyslipidemia","volume":"87","author":"Barreto-Filho","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/0026-0495(93)90145-E","article-title":"Growth hormone treatment improves serum lipids and lipoproteins in adults with growth hormone deficiency","volume":"42","author":"Cuneo","year":"1993","journal-title":"Metabolism"},{"key":"10.1016\/j.ghir.2010.05.003_bib33","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.2007-0609","article-title":"Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency","volume":"92","author":"Devin","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib34","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1136\/hrt.67.1.92","article-title":"Myocardial dysfunction in treated adult hypopituitarism: a possible explanation for increased cardiovascular mortality","volume":"67","author":"Shahi","year":"1992","journal-title":"Br. Heart J."},{"key":"10.1016\/j.ghir.2010.05.003_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1046\/j.1365-2265.1998.00281.x","article-title":"Left ventricular function in young adults with childhood and adulthood onset growth hormone deficiency","volume":"48","author":"Longobardi","year":"1998","journal-title":"Clin. Endocrinol. (Oxf)"},{"key":"10.1016\/j.ghir.2010.05.003_bib36","first-page":"1874","article-title":"Improved cardiovascular risk factors and cardiac performance after 12months of growth hormone (GH) replacement in young adult patients with GH deficiency","volume":"86","author":"Colao","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib37","first-page":"1658","article-title":"Cardiac structural and functional abnormalities in adult patients with growth hormone deficiency","volume":"77","author":"Merola","year":"1993","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib38","first-page":"659","article-title":"Cardiac performance and mass in adults with hypopituitarism: effects of one year of growth hormone treatment","volume":"80","author":"Valcavi","year":"1995","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib39","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1210\/jcem.87.5.8509","article-title":"Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency","volume":"87","author":"Biller","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jcem.87.2.8216","article-title":"Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency?","volume":"87","author":"Hartman","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib41","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1210\/jc.2008-2671","article-title":"Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly","volume":"94","author":"Wexler","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2010.05.003_bib42","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/0002-9149(87)91133-7","article-title":"Echocardiographic criteria for left ventricular hypertrophy: the Framingham Heart Study","volume":"59","author":"Levy","year":"1987","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ghir.2010.05.003_bib43","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1161\/01.CIR.55.4.613","article-title":"Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method","volume":"55","author":"Devereux","year":"1977","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2010.05.003_bib44","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.echo.2008.11.023","article-title":"Recommendations for the evaluation of left ventricular diastolic function by echocardiography","volume":"22","author":"Nagueh","year":"2009","journal-title":"J. Am. Soc. Echocardiogr."},{"key":"10.1016\/j.ghir.2010.05.003_bib45","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jcmg.2008.05.012","article-title":"Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) Echocardiographic Study","volume":"1","author":"Verma","year":"2008","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.ghir.2010.05.003_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/j.1365-2265.2008.03292.x","article-title":"A 2008 The GH\/IGF axis and the cardiovascular system: clinical implications","volume":"69","author":"Colao","year":"2008","journal-title":"Clin. Endocrinol. (Oxf)"}],"container-title":["Growth Hormone & IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637410000614?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637410000614?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:45:42Z","timestamp":1761086742000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637410000614"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,10]]},"references-count":46,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,10]]}},"alternative-id":["S1096637410000614"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2010.05.003","relation":{},"ISSN":["1096-6374"],"issn-type":[{"type":"print","value":"1096-6374"}],"subject":[],"published":{"date-parts":[[2010,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growth hormone status predicts left ventricular mass in patients after cure of acromegaly","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2010.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 Growth Hormone Research Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}